The marine biodiscovery pipeline and ocean medicines of tomorrow

Journal of the Marine Biological Association of the United Kingdom

Volumn 96, Issue 1, 2016, Pages 151-158

  Jaspars, Marcel ^a   De Pascale, Donatella ^b   Andersen, Jeanette H ^c   Reyes, Fernando ^d   Crawford, Alexander D ^e   Ianora, Adrianna ^f  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c UNIVERSITY OF TROMSØ   (Norway)

^d Health Sciences Technology Park   (Spain)

^e DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^f STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

drug discovery; ocean medicines; PharmaSea project

Indexed keywords

DEVELOPMENT PROJECT; DISEASE TREATMENT; DRUG; EUROPEAN UNION; LITERATURE REVIEW; MARINE ECOSYSTEM; MEDICINE; OCEAN; RESEARCH PROGRAM; SECONDARY METABOLITE;

EID: 84962476646     PISSN: 00253154     EISSN: 14697769     Source Type: Journal    
DOI: 10.1017/S0025315415002106     Document Type: Article

References (34)

1. Audoin C., Bonhomme D., Ivanisevic J., De la Cruz M., Cautain B., Monteiro M.C., Reyes F., Rios L., Perez T., and Thomas O. (2013) Balibalosides, an original family of glucosylated sesterterpenes produced by the Mediterranean sponge Oscarella balibaloi. Marine Drugs 11, 1477-1489
2. Bérdy J. (2012) Thoughts, and facts about antibiotics: where we are now, and where we are heading. Journal of Antibiotics (Tokyo) 65, 385-395
3. Blunt J.W., Copp B.R., Keyzers R.A., Munro M.H.G., and Prinsep M.R. (2015) Marine natural products. Nature Product Report 32, 116-211
4. Cambon-Bonavita M.A., Raguenes G., Jean J., Vincent P., and Guezennec J. (2002) A novel polymer produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. Journal of Applied Microbiology 93, 310-315
5. Cunliffe V.T. (2015) Building a zebrafish toolkit for investigating the pathobiology of epilepsy, and identifying new treatments for epileptic seizures. Journal of Neuroscience Methods. doi: 10.1016/j.jneumeth.2015.07.015
6. Daly N.L., and Craik D.J. (2011) Conopeptides as novel options for pain management. Drugs Future 36, 25-32
7. Dias D.A., Urban S., and Roessner U. (2012) A historical overview of natural products in drug discovery. Metabolites 2, 303-336
8. European Marine Board (2013) Linking oceans, and human health: a strategic research priority for Europe. Ostend: Position paper 19 of the European Marine Board
9. Fiedor J., and Burda K. (2014) Potential role of carotenoids as antioxidants in human health, and disease. Nutrients 6, 466-488
10. Gammone M.A., and D'Orazio N. (2015) Anti-obesity activity of the marine carotenoid fucoxanthin. Marine Drugs 13, 2196-2214
11. Gerwick W.H., and Moore B.S. (2012) Lessons from the past, and charting the future of marine natural products drug discovery, and chemical biology. Chemistry & Biology 19, 85-98
12. Glaser K.B., and Mayer A.M. (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochemical Pharmacology 78, 440-448
13. Hirata Y., and Uemura D. (1986) Halichondrins-antitumor polyether macrolides from a marine sponge. Pure, and Applied Chemistry 58, 701-710
14. Jang H.J., Nam S.-J., Locke J.B., Kauffman C.A., Beatty D.S., Paul L.A., and Fenical W. (2013) Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angewandte Chemie International Edition 52, 7822-7824
15. Katz J., Janik J.E., and Younes A. (2011) Brentuximab Vedotin (SGN-35) Clinical Cancer Research 17, 6428-6436
16. Klotz U. (2006) Ziconotide - a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain - a short review. International Journal of Clinical Pharmacology, and Therapy 44, 478-483
17. Lacret R., Oves-Costales D., Gómez C., Díaz C., De la Cruz M., Pérez-Victoria I., Vicente F., Genilloud O., and Reyes F. (2015) New ikarugamycin derivatives with antifungal, and antibacterial properties from Streptomyces zhaozhouensis. Marine Drugs 13, 128-140
18. Lallier L.E., McMeel O., Greiber T., Vanagt T., Dobson A.D., and Jaspars M. (2014) Access to, and use of marine genetic resources: understanding the legal framework. Natural Product Report 31, 612-616
19. Larsson D.G.K. (2014) Pollution from drug manufacturing: review, and perspectives. Philosophical Transactions of the Royal Society B Biological Sciences 369, 20130571
20. Leoutsakos V. (2004) A short history of the thyroid gland. Hormones 3, 268-271
21. Lorente A., Makowski K., Albericio F. Álvarez M. (2014) Bioactive marine polyketides as potential, and promising drugs. Annals of Marine Biology, and Research 1, 1003
22. Martins A., Vieira H., Gaspar H., and Santos S. (2014) Marketed marine natural products in the pharmaceutical, and cosmeceutical industries: tips for success. Marine Drugs 12, 1066-1101
23. Mayer A.M.S., Glaser K.B., Cuevas C., Jacobs R.S., Kem W., Little R.D., McIntosh J.M., Newman D.J., Potts B.C., and Shuster D.E. (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends in Pharmacology Science 31, 255-265
24. Mayer A.M.S., Rodríguez A.D., Taglialatela-Scafati O., and Fusetani N. (2013) Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune, and nervous systems, and other miscellaneous mechanisms of action. Marine Drugs 11, 2510-2573
25. Menis J., and Twelves C. (2011) Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer: Targets Therapy 3, 101-111
26. Mora C., Tittensor D.P., Adl S., Simpson A.G.B., and Worm B. (2011) How many species are there on earth, and in the ocean?. PLoS Biol 9, e1001127
27. Newman D.J., and Cragg G.M. (2014) Marine-sourced anti-cancer, and cancer pain control agents in clinical, and late preclinical development. Marine Drugs 12, 255-278
28. Potts B.C., Albitar M.X., Anderson K.C., Baritaki S., Berkers C., Bonavida B., Chandra J., Chauhan D., Cusack J.C. Jr, Fenical W., Ghobrial I.M., Groll M., Jensen P.R., Lam K.S., Lloyd G.K., McBride W., McConkey D.J., Miller C.P., Neuteboom S.T., Oki Y., Ovaa H., Pajonk F., Richardson P.G., Roccaro A.M., Sloss C.M., Spear M.A., Valashi E., Younes A., and Palladino M.A. (2011) Marizomib, a proteasome inhibitor for all seasons: preclinical profile, and a framework for clinical trials. Current Cancer Drug Targets 11, 254-284
29. Rangel M., and Falkenberg A. (2015) An overview of the marine natural products in clinical trials, and on the market. Journal of Coastal Life Medicine 3, 421-428
30. Rocha-Martin J., Harrington C., Dobson A.D.W., and O'Gara F. (2014) Emerging strategies, and integrated systems microbiology technologies for biodiscovery of marine bioactive compounds. Marine Drugs 12, 3516-3559
31. Sagar S., Kaur M., and Minneman K.P. (2010) Antiviral lead compounds from marine sponges. Marine Drugs 8, 2619-2638
32. Schoffski P., Dumez H., Wolter P., Stefan C., Wozniak A., Jimeno J., and Van Oosterom A.T. (2008) Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opinion on Pharmacotherapy 9, 1609-1618
33. Torjesen I. (2015) Drug development: the journey of a medicine from lab to shelf. Pharmaceutical Journal. http://www.pharmaceutical-journal. com/PJ-March-2015-online/926.issue
34. VanHook A.M. (2010) Behavioural fingerprinting. Science Signaling 10, 3, pp. ec22